View abstract

This abstract is assigned to sessions

Presentation type	E-poster
Title	Overall Visual Outcomes from a Real-World Study of Presbyopia-Correcting IOLs in a Large Population

Purpose	To present real-world visual and patient-reported outcomes in a large cohort of patients bilaterally implanted with the AcrySof IQ Vivity presbyopia-correcting IOL
Methods	Multicenter, ambispective registry study conducted in Europe, Australia and New Zealand. This cohort includes 4% post-corneal refractive surgery subjects and 28% with associated ocular comorbidities. At 3-6 months post-op, subjects bilaterally implanted underwent visual performance assessments. Patient satisfaction and spectacle independence were assessed with validated questionnaires. Patient reports of visual disturbance were also assessed
Results	910 subjects were available for analysis. The mean age was 67.1 ± 9.3 years. Binocular mean UCDVA was 0.01 ± 0.10 logMAR, UCIVA was 0.08 ± 0.12 logMAR, and UCNVA was 0.25 ± 0.15 logMAR. Mean MRSE (first eye) was -0.19 ± 0.39 D (23.7% had mini-monovision). Most subjects (91.4%) reported being satisfied with their vision. The percentage of subjects reporting never/rarely needing to wear glasses to see up close was 60.2%, at arm’s length 89.2%, and far away 93.4%. The percentage of subjects reporting “none” for seeing halos was 91.5%, for glare 91.6%, and for starbursts 94.6%
Conclusion	In this real-world study in a diverse large population of subjects bilaterally implanted with the AcrySof IQ Vivity IOL, we have demonstrated excellent distance (20/20), intermediate (~20/25), and functional near (~20/32) visual acuity. In general, subjects reported high visual satisfaction with little or no difficulty in performing daily activities and very little visual disturbances.
Conflict of interest	Yes
Details of conflicting interests	Principal investigator in the Alcon Study

Authors 1

Last name	CRAHAY
Initials	F
Department	hopital de la citadelle
City	liège